Targeting of newly synthesized membrane proteins to the endoplasmic reticulum (ER) is an important cellular process. Most membrane proteins are recognized and targeted co-translationally by the signal recognition particle (SRP). A number of membrane proteins (eg. SNAREs, apoptosis factors, and protein translocation components) are 'tail-anchored' by a single carboxy-terminal transmembrane domain. Due to this topological constraint, these proteins are not able to follow the SRP-dependent co-translational pathway that typifies most integral membrane proteins. Instead, these proteins must find their correct membrane for insertion post-translationally (1). The ATPase Get3 was the first protein identified directly involved in TA targeting and is part of the Get pathway (Guided Entry of Tail-anchored proteins) that also contains the ER membrane proteins Get1/2 and the putative ribosome receptor proteins Get4/5 (2). Multiple studies have shown that Get3 binds directly to the hydrophobic tail-anchors and, in conjunction with ribosome and ER factors, utilizes an ATP cycle to bind and then release TA proteins at the ER membrane.

To get a detailed mechanistic view of how Get3 performs its important targeting function a team at Caltech led by Bil Clemons used data collected at SSRL Beam Line 12-2 to determine the three-dimensional structure of Get3/TRC40 (Fig. 1). The structure of Get3 in the ADP form was a hexamer (Fig. 1a). It is expected that Get3 functions as a dimer (Fig. 1b). Based on homology to other proteins, the structure allowed for the prediction that binding of ATP would lead to a dramatic conformational change bringing two hydrophobic grooves together to form a TA-binding pocket. The team probed functional interfaces and essential residues using phenotypic rescue allowing them to define a model of how Get3 couples ATP hydrolysis to the binding and release of TA-proteins.

Figure 1a		Figure 1b